Protein-stabilized silver nanoparticles encapsulating gentamycin for the therapy of bacterial biofilm infections

Nanomedicine (Lond). 2021 Apr;16(10):801-818. doi: 10.2217/nnm-2020-0451. Epub 2021 Apr 26.

Abstract

Aim: An antibiotic-conjugated protein-stabilized nanoparticle hybrid system was developed to combat the challenges faced during the treatment of drug-resistant bacterial biofilm-associated infections. Materials & methods: Biocompatible silver nanoparticles were synthesized using intracellular protein and gentamycin was attached. The resulting nanohybrid was characterized and its antibacterial efficiency was assessed against Gram-positive, Gram-negative and drug-resistant bacteria. Results: Spectroscopic and electron microscopic analysis revealed that the nanoparticles were spherical with a diameter of 2-6 nm. Red-shifting of the surface plasmon peak and an increase in hydrodynamic diameter confirmed attachment of gentamycin. The nanohybrid exhibited antibacterial efficiency against a range of bacteria with the ability to inhibit and disrupt bacterial biofilm. Conclusion: A unique nanohybrid was designed that has potential to be used to control drug-resistant bacterial infections in the future.

Keywords: antibiotic-entrapped nanohybrid; antimicrobial therapy; bacteria; biocompatible; biofilm; drug resistance; protein-coated nanoparticle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Infections*
  • Biofilms
  • Gentamicins
  • Humans
  • Metal Nanoparticles*
  • Microbial Sensitivity Tests
  • Silver

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Silver